MOFLAXA 400mg / 250ml infusion solution medication leaflet

J01MA14 moxifloxacin • Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones

Moxifloxacinum is a fluoroquinolone antibiotic used to treat bacterial infections, including respiratory infections, sinusitis, skin infections, and intra-abdominal infections. It works by inhibiting bacterial enzymes essential for DNA replication, thereby killing the bacteria.

The medication is administered orally or intravenously, depending on the severity of the infection. It is effective against a wide range of bacteria, including strains resistant to other antibiotics.

Side effects may include nausea, diarrhea, dizziness, and, in rare cases, severe reactions such as tendinitis or tendon rupture. It is important to inform your doctor about any side effects or other medications you are taking.

Consult your doctor before use, especially if you have liver, kidney, or other health conditions. Use Moxifloxacinum as directed to prevent the development of bacterial resistance.

General data about MOFLAXA 400mg / 250ml

Substance: moxifloxacin

Date of last drug list: 01-07-2020

Commercial code: W62717002

Concentration: 400mg / 250ml

Pharmaceutical form: infusion solution

Quantity: 5

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: KRKA, D.D., NOVO MESTO - SLOVENIA

Holder: KRKA, D.D., NOVO MESTO - SLOVENIA

Number: 12744/2019/02

Shelf life: 3 years-after packing for marketing;after the first opening-it is used immediately

Pharmaceutical forms available for moxifloxacin

Concentrations available for moxifloxacin

400mg, 400mg/250ml, 5mg/ml